SBP Name |
Highest Status |
Template |
Expression System |
Selection Method |
Details |
Ref |
Affimer anti-Fibrinogen/Fibrin F5 |
Research |
Adhiron |
Escherichia coli BL21 (DE3) |
Phage display |
SBP Info
|
[1] |
Affimer anti-Fibrinogen/Fibrin G2 |
Research |
Adhiron |
Escherichia coli BL21 (DE3) |
Phage display |
SBP Info
|
[1] |
Affimer anti-ySUMO clone 10 |
Research |
Adhiron92 |
Escherichia coli |
Phage display |
SBP Info
|
[2] |
Affimer anti-ySUMO clone 15 |
Research |
Adhiron92 |
Escherichia coli |
Phage display |
SBP Info
|
[2] |
Affimer anti-ySUMO clone 20 |
Research |
Adhiron92 |
Escherichia coli |
Phage display |
SBP Info
|
[2] |
Affimer anti-ySUMO clone 22 |
Research |
Adhiron92 |
Escherichia coli |
Phage display |
SBP Info
|
[2] |
Affimer anti-HER4 |
Research |
N.A. |
Escherichia coli |
Phage display |
SBP Info
|
[3] |
Affimer anti-HVT-UL49 |
Research |
N.A. |
Escherichia coli |
Phage display |
SBP Info
|
[3] |
Affimer anti-K33-diubiquitin |
Research |
Adhiron |
N.A. |
Phage display |
SBP Info
|
[4] |
Affimer anti-K6-diubiquitin |
Research |
Adhiron |
N.A. |
Phage display |
SBP Info
|
[4] |
Affimer anti-p85 |
Research |
N.A. |
Escherichia coli |
Phage display |
SBP Info
|
[3] |
Affimer anti-TNC |
Research |
N.A. |
Escherichia coli |
Phage display |
SBP Info
|
[3] |
Affimer anti-VEGFR-2 A9 |
Research |
N.A. |
Escherichia coli |
Phage display |
SBP Info
|
[3] |
Affimer anti-VEGFR-2 B8 |
Research |
N.A. |
Escherichia coli |
Phage display |
SBP Info
|
[3] |
Affimer MIA-1 |
Research |
N.A. |
Escherichia coli |
Phage display |
SBP Info
|
[5] |
Affimer MIA-2 |
Research |
N.A. |
Escherichia coli |
Phage display |
SBP Info
|
[5] |
Affimer anti-Fc-gamma-RIIIA F4 |
Research |
N.A. |
N.A. |
Phage display |
SBP Info
|
[6] |
Affimer anti-Fc-gamma-RIIIA G3 |
Research |
N.A. |
N.A. |
Phage display |
SBP Info
|
[6] |
Affimer anti-Alpha-2-AP AVA-016 |
Research |
N.A. |
N.A. |
N.A. |
SBP Info
|
[7] |
Affimer anti-CD27 AVA-014 |
Research |
N.A. |
N.A. |
N.A. |
SBP Info
|
[7] |
Affimer anti-CD3/CD22 AVA-012 |
Research |
N.A. |
N.A. |
N.A. |
SBP Info
|
[7] |
Affimer anti-CD3/CD3E AVA-002 |
Research |
N.A. |
N.A. |
N.A. |
SBP Info
|
[7] |
Affimer anti-CPMV clone 3 |
Research |
N.A. |
N.A. |
N.A. |
SBP Info
|
[8] |
Affimer anti-GITR AVA-018 |
Research |
N.A. |
N.A. |
N.A. |
SBP Info
|
[7] |
Affimer anti-LAG-3 AVA-017 |
Research |
N.A. |
N.A. |
N.A. |
SBP Info
|
[7] |
Affimer anti-PD-L1 AVA-004 |
Research |
N.A. |
N.A. |
N.A. |
SBP Info
|
[7] |
Affimer anti-PD-L1/LAG-3 AVA-021 |
Research |
N.A. |
N.A. |
N.A. |
SBP Info
|
[7] |
Affimer anti-SARS-CoV-2 |
Research |
N.A. |
N.A. |
N.A. |
SBP Info
|
[7] |
Affimer anti-TPBG AVA-020 |
Research |
N.A. |
N.A. |
N.A. |
SBP Info
|
[7] |
Affimer anti-Trastuzumab AVA00106 |
Research |
N.A. |
N.A. |
N.A. |
SBP Info
|
[7] |
|
|
|
|
|
|
|